WHY GENOBYTE
Competitor differentiator
PRECISYA
GenoByte’s Parent Technology Partner is the only company that provides holistic, personalized, and prescriptive solutions. We use big data and AI-enabled proprietary algorithms supported genomic analyses, blood biomarkers, tailored supplements and prescription medicines, and nutritional guidance.
METHODOLOGY
We display the difference between our Genotyping by Sequencing Methodology and the most common methodology used by laboratories and hospitals, the NGS (Exome). Exome analyses less than 2% of DNA strands, which means it analyses specific genes and only the parts of the genes called exons. The exons are regions that give coding instructions for protein production. We also analyze exons, but we are not limited to exons only. The introns are the other part of DNA that have a very important function, too: the regulation of the genes. Without the introns and their variations, the regulation of protein production and its functioning wouldn’t work. Also, NGS (Exome) analyses specific genes, searching for mutations corresponding to less than 1% of the variation in the population. Currently, only 280,000 mutations are analyzed in NGS (Exome). We analyze much more, with a minimum of 800,000 variations per batch.
ETHNICITY PRECISION
The breakdown analysis is very important for accuracy. Few competitors consider ethnicity variation as important. Precisya applies complex formulas to determine the risk of each patient based on their ethnicity composition.
VARIANTS
Big Data empowers us. We analyze a much bigger number of genetic variants. As the human body has, on average, 6 million variants, the closest we get to this number will allow us to have a high precision result. It’s impossible to analyze people’s health using just a dozen variants.
STRAND INVERSION ALOGRITHM
Another big differential is the Strand Inversion Algorithm, which calculates when the result of a substitution (allele) or genotype must
be inverted. This corresponds to an increase of more than 24% compared to any laboratory worldwide.
ACCOMPLISHED
More than 2.5 million genomic tests were administered over seven years, treating more than 300,000 consumer health patients.
PROVEN RECORD OF SUCCESS
o More than 2.5 million tests generated
o Done 1.2 million population analysis
o More than 300,000 customers served
o More than 4,000 healthcare practitioners prescribing
BIG DATA ANALYTICS & AI-ENABLED PRECISION HEALTH PLATFORM
Precisya uses 13 propriety algorithms analyzing more than 3 billion base pairs for each individual to orchestrate Holistic and Actionable Health Insights.
Precisya uses genomic data and blood biomarkers to improve patient health, wellness, and longevity.
GLOBAL PRESENCE
Precisya, now in 12 countries, is considered the most advanced Genetic company. We analyze 26,617 genes, 40+ million genetic markers, and 5,000+
diseases for each genetic test. To date, we have accomplished 2.2 million tests.
SCIENTIFIC PUBLICATIONS
Precisya analysis is based on the Exome, Microarray, and WGS. The genomic universe of Precisya includes 25+ million Scientific Publications.
HOLISTIC VIEW OF THE GENETIC LANDSCAPE
Most available genetic tests focus on the Exome, which represents just 2% of our DNA, scrutinizing variations within this limited
area while neglecting vast regions known as Introns. This oversight means significant genetic data is overlooked, which could be pivotal in disease prevention and treatment. Most genetic tests do not provide a holistic view of an individual’s genetic landscape. They fail to show how different genes interact with each other or their collective impact on our health, akin to how our organs such as the brain, heart, liver, and pancreas do not operate in isolation but are interdependent.
MEDGENECARE INTELLIGENCE PORTAL
MedGeneCare empowers healthcare professionals with the tools to turn genetic insights into actionable, life-enhancing decisions, setting a new standard in personalized healthcare. PRECISYA offers consulting professionals an intelligence portal that integrates the genetic results, the metabolic test
results, and client history and preferences to generate recommendations that are precise, comprehensive, and actionable recommendations.
PERSONALIZED METABOLIC PATHWAYS
We recognize the critical need for advanced tools to decipher complex interactions within the human body using the biochemical metabolic pathways. This unique tool, Personalized Metabolic Pathways, represents a pioneering step in this direction. It offers an unparalleled visualization of the body’s most crucial metabolic pathways, providing rapid insights into the main functions, deficiencies, risks, advantages, and potential origins of existing or pre-existing diseases.
The Personalized Metabolic Pathways tool illustrates how various pathways operate and provides specific information on how different genes influence these pathways. This includes the impact of genetic variations on enzyme activities, the metabolism of vitamins and minerals, and the body’s response to different dietary components.